Volume 51, Issue 6, Pages (June 2007)

Slides:



Advertisements
Similar presentations
Application of Ultrasound and Ultrasound-Guided Intervention for Evaluating Elbow Joint Pathologies Chia-Wei Lin, Yan-Hao Chen, Wen-Shiang Chen Journal.
Advertisements

Early Detection of Prostate Cancer in 2007
Endothelial nitric oxide synthase is not necessary for the early phase of ischemic preconditioning in the mouse  Yiru Guo, Qianhong Li, Wen-Jian Wu, Wei.
Volume 49, Issue 1, Pages (January 2006)
The PSA Era is not Over for Prostate Cancer
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Metabolomic study of cisplatin-induced nephrotoxicity
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
Volume 54, Issue 5, Pages (November 2008)
Volume 62, Issue 4, Pages (October 2012)
Volume 67, Issue 4, Pages (April 2015)
Combination of Alfuzosin and Sildenafil is Superior to Monotherapy in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction  Steven A. Kaplan,
Volume 54, Issue 5, Pages (November 2008)
Volume 54, Issue 1, Pages (July 2008)
Volume 49, Issue 1, Pages (January 2006)
Volume 62, Issue 6, Pages (December 2012)
Let the Games Begin (with EAU Approval)
Long-term analgesic effect of a single dose of anti-NGF antibody on pain during motion without notable suppression of joint edema and lesion in a rat.
Schwann cell injuries of radial nerve after lead (Pb) exposure in rats
Prostate Cancer Epidemic in Sight?
Volume 57, Issue 6, Pages (June 2010)
Volume 64, Issue 4, Pages (October 2013)
John P. Mulhall, Francesco Montorsi  European Urology 
Daily Administration of Phosphodiesterase Type 5 Inhibitors for Urological and Nonurological Indications  Anthony J. Bella, Ling X. DeYoung, Mussa al-Numi,
Volume 64, Issue 4, Pages (October 2013)
Volume 53, Issue 2, Pages (February 2008)
A 43kD protein from the herb, Cajanus indicus L
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey  John B. McKinlay, Carol L. Link  European.
Volume 51, Issue 3, Pages (March 2007)
Volume 58, Issue 5, Pages (November 2010)
A Systematic Review of Graft Augmentation Urethroplasty Techniques for the Treatment of Anterior Urethral Strictures  Altaf Mangera, Jacob M. Patterson,
Influence of nonsteroidal anti-inflammatory drug treatment duration and time of onset on recovery from exercise-induced muscle damage in rats1  Benoît.
Photoselective Vaporesection of the Prostate with a Front-firing Lithium Triborate Laser: Surgical Technique and Experience After 215 Procedures  Yong-Guang.
Prostate Cancer Epidemic in Sight?
James N. Armitage, Stuart O. Irving, Neil A. Burgess  European Urology 
Volume 48, Issue 4, Pages (October 2005)
The PSA Era is not Over for Prostate Cancer
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 53, Issue 6, Pages (June 2008)
Volume 61, Issue 1, Pages (January 2012)
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
The Economic Costs of Overactive Bladder in Germany
Volume 50, Issue 5, Pages (November 2006)
Volume 20, Issue 6, Pages (December 2014)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 5, Issue 2, Pages (February 2007)
Injury of primary afferent neurons may contribute to osteoarthritis induced pain: an experimental study using the collagenase model in rats  S. Adães,
A.Y Onaolapo, A.A. Adebayo, O.J Onaolapo  Pathophysiology 
Blockade of nociceptive sensory afferent activity of the rat knee joint by the bradykinin B2 receptor antagonist fasitibant  A. Gomis, S. Meini, A. Miralles,
Polydeoxyribonucleotide (PDRN) restores blood flow in an experimental model of peripheral artery occlusive disease  Alessandra Bitto, MD, Francesca Polito,
Testicular Cancer Variations in Time and Space in Europe
Volume 14, Issue 1, Pages (July 2006)
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
Volume 8, Issue 3, Pages (June 2002)
A quantitative approach to measure joint pain in experimental osteoarthritis—evidence of a role for nitric oxide  R.R. Castro, M.S., F.Q. Cunha, Ph.D,
European Urology is “Your” Journal
Volume 72, Issue 3, Pages (August 2007)
Decreased lung ischemia-reperfusion injury in rats after preoperative administration of cyclosporine and tacrolimus  B. Krishnadasan, MD, B. Naidu, MBBS,
Cold-stress induces thymocyte apoptosis in the rat
Volume 56, Issue 3, Pages (September 1999)
Oral contraceptive administration aggravates nitric oxide synthesis inhibition-induced high blood pressure in female rats  L.A. Olatunji, A.O. Soladoye 
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Intra-articular injections of hyaluronan solutions of different elastoviscosity reduce nociceptive nerve activity in a model of osteoarthritic knee joint.
C. Pascual Garrido, A. A. Hakimiyan, L. Rappoport, T. R. Oegema, M. A
Volume 67, Issue 5, Pages (May 2005)
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Effect of varying frequency, intensity, and pulse duration of transcutaneous electrical nerve stimulation on primary hyperalgesia in inflamed rats  Priya.
Cardioprotection by sevoflurane against reperfusion injury after cardioplegic arrest in the rat is independent of three types of cardioplegia  D. Ebel,
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 51, Issue 6, Pages 1724-1731 (June 2007) Neuroimmunophilin Ligands Protect Cavernous Nerves after Crush Injury in the Rat: New Experimental Paradigms  Heather Valentine, Yi Chen, Hongzhi Guo, Jocelyn McCormick, Yong Wu, Sena F. Sezen, Ahmet Hoke, Arthur L. Burnett, Joseph P. Steiner  European Urology  Volume 51, Issue 6, Pages 1724-1731 (June 2007) DOI: 10.1016/j.eururo.2006.11.026 Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 1 ICP is maintained in UCI following intraperitoneal treatment of GPI. The right CN was crushed as described in methods. Both vehicle and GPI (15mg/kg, ip) treatment preceded the nerve crush by 30min. Twenty-four hours later, ICP was measured during a 60-s electrical stimulation of the left CN (control) and the right CN (crush). (A). The ICP responses were recorded as a function of time and depicted for both the GPI-treated (left panel) and the vehicle-treated (right panel) rats. (B). Comparison of the maximum ICP response data from graphs in A. Statistical difference defined as *p<0.01, n=6 per group. CN=cavernous nerve; GPI=GPI-1046; ICP=intracavernosal pressure; ip=intraperitoneal; UCI=unilateral crush injury. European Urology 2007 51, 1724-1731DOI: (10.1016/j.eururo.2006.11.026) Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 2 Intraperitoneal administration of FK506 and GPI maintains ICP responses in rats with UCI. Rats were treated with vehicle, GPI (15mg/kg), or FK506 (1mg/kg) for 30min prior to UCI. Twenty-four hours later, ICP was measured during a 60-s electrical stimulation of the left CN (control) and the right CN (crush). The ICP response was expressed as %ICP of the uninjured CN stimulation for UCI. Statistical difference defined as *p<0.05, **p<0.01, n=6 per group. See Fig. 1 for definitions of abbreviations. European Urology 2007 51, 1724-1731DOI: (10.1016/j.eururo.2006.11.026) Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 3 Oral administration of GPI maintains ICP responses in rats with UCI. Both the vehicle and GPI (30mg/kg) treatment preceded the nerve crush by 30min. Twenty-four hours later, ICP was measured during a 60-s electrical stimulation of the left CN (control) and the right CN (crush). Data were expressed as mean±SE of maximum ICP. Statistical difference defined as *p<0.05, n=8 per group. See Fig. 1 for definitions of abbreviations. European Urology 2007 51, 1724-1731DOI: (10.1016/j.eururo.2006.11.026) Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 4 Oral administration of GPI maintains ICP responses in rats 7 d after UCI. Rats were treated for 7 d with vehicle or GPI starting 30min prior to UCI. (A) Vehicle or GPI (30mg/kg/d). (B) Vehicle or GPI (7.5mg/kg, po). Seven days after UCI, ICP was measured during a 60-s electrical stimulation of the left CN (control) and the right CN (crush). The ICP response was expressed as %ICP of the uninjured CN stimulation. Statistical difference defined as *p<0.01, n=8/group. See Fig. 1 for definitions of abbreviations. European Urology 2007 51, 1724-1731DOI: (10.1016/j.eururo.2006.11.026) Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 5 Oral administration of GPI maintains ICP responses in rats with BCI. Rats were administered vehicle or GPI (30mg/kg) 30min prior to BCI. A group of sham rats were run in parallel for comparison. Twenty-four hours later, ICP was measured during a 60-s electrical stimulation of the left CN (control) and the right CN (crush). Data was expressed as mean±SE of maximum ICP. Statistical difference defined as **p<0.001, n=8 per group. BCI=bilateral crush injury; see Fig. 1 for definitions of other abbreviations. European Urology 2007 51, 1724-1731DOI: (10.1016/j.eururo.2006.11.026) Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 6 GPI treatment prevents degeneration of unmyelinated axons in the distal CN. Rats with UCI were treated with vehicle or GPI (15mg/kg, ip), and the CNs were evaluated for axonal degeneration by EM (see Methods). (A) Quantitation of the right CN (crush) unmyelinated axon survival at 7 d after injury in vehicle- or GPI- treated animals (N=4 per group, p=0.007). Representative EMs of (B) left CN (control); (C) right CN (crush) with GPI treatment; (D) right CN (crush) with vehicle treatment. There are more degenerating unmyelinated axons in the vehicle-treated nerves (narrow arrows point to some of the degenerating axons; thick arrow points to a degenerating small myelinated axon). EM=electron microscopy; see Fig. 1 for definitions of other abbreviations. European Urology 2007 51, 1724-1731DOI: (10.1016/j.eururo.2006.11.026) Copyright © 2006 European Association of Urology Terms and Conditions